Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum- sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study

Author(s):
Laar, R. van de; Zusterzeel, P.L.M.; Gorp, T. van; Buist, M.R.; Driel, W.J. van; Gaarenstroom, K.N.; Arts, H.J.G.; Huisseling, J.C.M. van; Hermans, R.H.M.; Pijnenborg, J.M.A.; Schutter, E.M.J.; Pelikan, H.M.P.; Vollebergh, J.H.A.; Engelen, M.J.A.; IntHout, J.; Kruitwagen, R.F.P.M.; Massuger, L.F.A.G.
Published
2014
Publication type
Article / Letter to editor
Secondary cytoreductive surgeryRecurrentPlatinum-sensitiveOvarian cancer
Date issued
2014-01-14
Language
English
Is part of
BMC Cancer
hdl
1887/106642
doi
10.1186/1471-2407-14-22